Cargando…
Nanomedicine for increasing the oral bioavailability of cancer treatments
ABSTRACT: Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications, including chemotherapeutics. In recent dec...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557561/ https://www.ncbi.nlm.nih.gov/pubmed/34717658 http://dx.doi.org/10.1186/s12951-021-01100-2 |
_version_ | 1784592397591642112 |
---|---|
author | Parodi, Alessandro Buzaeva, Polina Nigovora, Daria Baldin, Alexey Kostyushev, Dmitry Chulanov, Vladimir Savvateeva, Lyudmila V. Zamyatnin, Andrey A. |
author_facet | Parodi, Alessandro Buzaeva, Polina Nigovora, Daria Baldin, Alexey Kostyushev, Dmitry Chulanov, Vladimir Savvateeva, Lyudmila V. Zamyatnin, Andrey A. |
author_sort | Parodi, Alessandro |
collection | PubMed |
description | ABSTRACT: Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications, including chemotherapeutics. In recent decades, the fields of material science and nanomedicine have generated several delivery platforms with high potential for overcoming multiple barriers associated to oral administration. This review describes the properties of several nanodelivery systems that improve the bioavailability of orally administered therapeutics, highlighting their advantages and disadvantages in generating successful anticancer oral nanomedicines. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8557561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85575612021-11-01 Nanomedicine for increasing the oral bioavailability of cancer treatments Parodi, Alessandro Buzaeva, Polina Nigovora, Daria Baldin, Alexey Kostyushev, Dmitry Chulanov, Vladimir Savvateeva, Lyudmila V. Zamyatnin, Andrey A. J Nanobiotechnology Review ABSTRACT: Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications, including chemotherapeutics. In recent decades, the fields of material science and nanomedicine have generated several delivery platforms with high potential for overcoming multiple barriers associated to oral administration. This review describes the properties of several nanodelivery systems that improve the bioavailability of orally administered therapeutics, highlighting their advantages and disadvantages in generating successful anticancer oral nanomedicines. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2021-10-30 /pmc/articles/PMC8557561/ /pubmed/34717658 http://dx.doi.org/10.1186/s12951-021-01100-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Parodi, Alessandro Buzaeva, Polina Nigovora, Daria Baldin, Alexey Kostyushev, Dmitry Chulanov, Vladimir Savvateeva, Lyudmila V. Zamyatnin, Andrey A. Nanomedicine for increasing the oral bioavailability of cancer treatments |
title | Nanomedicine for increasing the oral bioavailability of cancer treatments |
title_full | Nanomedicine for increasing the oral bioavailability of cancer treatments |
title_fullStr | Nanomedicine for increasing the oral bioavailability of cancer treatments |
title_full_unstemmed | Nanomedicine for increasing the oral bioavailability of cancer treatments |
title_short | Nanomedicine for increasing the oral bioavailability of cancer treatments |
title_sort | nanomedicine for increasing the oral bioavailability of cancer treatments |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557561/ https://www.ncbi.nlm.nih.gov/pubmed/34717658 http://dx.doi.org/10.1186/s12951-021-01100-2 |
work_keys_str_mv | AT parodialessandro nanomedicineforincreasingtheoralbioavailabilityofcancertreatments AT buzaevapolina nanomedicineforincreasingtheoralbioavailabilityofcancertreatments AT nigovoradaria nanomedicineforincreasingtheoralbioavailabilityofcancertreatments AT baldinalexey nanomedicineforincreasingtheoralbioavailabilityofcancertreatments AT kostyushevdmitry nanomedicineforincreasingtheoralbioavailabilityofcancertreatments AT chulanovvladimir nanomedicineforincreasingtheoralbioavailabilityofcancertreatments AT savvateevalyudmilav nanomedicineforincreasingtheoralbioavailabilityofcancertreatments AT zamyatninandreya nanomedicineforincreasingtheoralbioavailabilityofcancertreatments |